Daily Roundup

Thursday, 6th November 2025
Last updated: 21:00

VEE.ASX NAB.ASX SGI.ASX NEU.ASX AMC.ASX

Smooth Sailing Ahead for VEEM's Extreme Propulsion Package

VEEM Limited has just launched its most efficient propulsion system yet - the VEEM Extreme propulsion package. This cutting-edge offering includes a proprietary high-tensile alloy propeller, twisted rudder, and fully flow-aligned shaft line components that deliver up to an impressive 18.1% in fuel efficiency gains.

The VEEM Extreme propeller, manufactured from the company's new proprietary alloy, enables thinner blade profiles and better performance. Compared to an industry-standard propeller, the VEEM Extreme version achieved an 11.9% reduction in fuel burn and carbon footprint, with a top speed improvement of 3.36 knots to 43.05 knots. It also outperformed VEEM's current fully CNC-machined NiBral propellers, with a 6.2% reduction in fuel burn and speed improvements of 0.89 knots.

The complete VEEM Extreme shaft package, including the flow-aligned rudder and custom brackets and shaft, resulted in 72% less drag and 6.2% less fuel burn than a standard setup. Manly Fast Ferries has already seen the benefits, with plans to convert 6 more vessels to VEEM Extreme propellers over the next 18 months.

VEEM has truly raised the bar for efficient propulsion systems with its latest innovation.

NAB Delivers Solid FY25 Results Amid Evolving Landscape

National Australia Bank (NAB) has reported a solid set of financial results for the 2025 fiscal year, with a 1% lift in underlying profit despite a challenging environment.

Revenue increased 2.9%, driven by volume growth and stronger Markets & Treasury income. However, expenses were up 4.6%, including $130 million in payroll review and remediation charges. Excluding these charges, expenses rose 3.2%, reflecting higher personnel and technology costs, partially offset by productivity gains.

The pace of asset quality deterioration slowed in the second half of FY25, with credit impairment charges increasing to $833 million. NAB's CET1 ratio remained comfortably above target at 11.70%.

Looking ahead, NAB expects to deliver revenue growth of 3-5% and expense growth of 2-4% in FY26, with credit impairment charges expected to moderate. The bank remains optimistic about the outlook, with a clear strategy focused on improving customer experiences, growing business banking, driving deposit growth, and strengthening proprietary home lending.

NAB is well-positioned to navigate the evolving economic landscape and deliver sustainable growth and returns for shareholders.

Stealth Group Requests Trading Halt for Potential Acquisition

Stealth Group Holdings Ltd has requested a trading halt to manage its continuous disclosure obligations, pending an announcement related to a proposed acquisition.

The trading halt will remain in place until the commencement of normal trading on Monday, 10th November 2025, unless the company requests an earlier lift. Stealth Group is not aware of any other reason for the trading halt and has authorized the announcement to be made.

Investors will be keen to see what potential acquisition Stealth Group has in the works once the trading halt is lifted.

Neuren Pharmaceuticals Celebrates Record DAYBUE Sales

Neuren Pharmaceuticals has reported record Q3 2025 net sales of US$101.1 million for its partner Acadia Pharmaceuticals' DAYBUE drug, up 11% from the same period last year.

The strong performance was driven by a significant increase in patient numbers, with over 1,000 patients receiving DAYBUE shipments for the first time. Notably, around 74% of new prescriptions were written by community physicians, indicating expanded adoption beyond the Rett syndrome centers of excellence.

Acadia has narrowed its full-year 2025 guidance for DAYBUE US net sales to US$385 - 400 million, implying full-year 2025 US royalty income for Neuren of A$63 - 66 million.

Neuren Pharmaceuticals is clearly benefiting from the growing success of the DAYBUE drug, which continues to gain traction with both specialist and community physicians.

Amcor Delivers Solid Q1 Result, Reaffirms FY26 Outlook

Amcor has reported a strong start to fiscal year 2026, with its first full quarter as the combined Amcor and Berry business. Net sales were up 68% and adjusted EBIT increased 85% excluding currency impact, supported by synergies at the upper end of the expected range.

The company reaffirmed its fiscal 2026 outlook, including adjusted EPS growth of 12-17% on a constant currency basis and free cash flow of $1.8-1.9 billion. Amcor CEO Peter Konieczny highlighted the strong execution by the combined teams, with customers receptive to the expanded offerings and innovation capabilities.

Amcor is on track to deliver at least $260 million of synergy benefits in fiscal 2026 and expects to achieve the previously announced total pre-tax synergy benefits of $650 million by the end of fiscal 2028. The company also increased its quarterly dividend, reflecting confidence in the growth opportunities and ability to generate significant free cash flow.

Amcor's solid start to the year and reaffirmed outlook suggest the integration of Berry Global is progressing well, positioning the company for continued success.